NGS vs Culture Outcomes for Treatment of PJI
Launched by CENTER FOR INNOVATION AND RESEARCH ORGANIZATION · Feb 15, 2022
Trial Information
Current as of May 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (age \> 18 years)
- • Undergoing single stage revision or 1st stage resection arthroplasty/spacer placement for PJI (ICM-positive) of the hip or knee
- • Written informed consent
- Exclusion Criteria:
- • Ongoing participation in another clinical trial
- • Megaprosthesis
About Center For Innovation And Research Organization
The Center for Innovation and Research Organization (CIRO) is a leading clinical trial sponsor dedicated to advancing medical research through innovative methodologies and collaborative partnerships. With a focus on enhancing patient outcomes, CIRO conducts rigorous clinical trials across various therapeutic areas, employing cutting-edge technologies and data-driven approaches. Our mission is to bridge the gap between scientific discovery and clinical application, fostering an environment that supports the development of new treatments and therapies. Committed to ethical standards and patient safety, CIRO strives to contribute to the global body of medical knowledge while ensuring transparency and integrity in all research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
New York, New York, United States
Salt Lake City, Utah, United States
Weston, Florida, United States
Rochester, New York, United States
Lebanon, New Hampshire, United States
Philadelphia, Pennsylvania, United States
Cleveland, Ohio, United States
Staten Island, New York, United States
Patients applied
Trial Officials
Tiffany Morrison
Study Director
Center for Innovation and Research Organization
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials